 |
上海源葉生物科技有限公司
主營產品： S30260異硫氰酸胍,30259鹽酸胍,嗜熱菌蛋白酶 |
15
聯系電話
15921386130
公司信息
- 聯系人：
- 何小姐
- 電話：
- 86-021-61559134
- 手機：
- 15921386130
- 傳真：
- 86-021-55068248
- 地址：
- 上海市松江區長塔路465號6幢
- 郵編：
- 200433
- 網址：
- www.shyuanye.com
S80044
| 參考價 | 面議 |
具體成交價以合同協議為準
- 型號
- 品牌
- 廠商性質 生產商
- 所在地
更新時間：2025-05-15 19:28:02瀏覽次數：154
聯系我們時請說明是化工儀器網上看到的信息，謝謝!
- 提示：詳情請下載說明書。
- 產品描述： TAK-733 is a potent and selective MEK allosteric site inhibitor with an IC50 of 3.2 nM.
- 靶點： MEK:3.2 nM (IC50)
- 體內研究： The pharmacokinetics of TAK-733 is evaluated in nude mouse, rat, dog and monkey. Low clearance and high oral bioavailability are observed in all species. TAK-733 demonstrates broad antitumor activity in mouse xenograft models of human cancer including models of melanoma, colorectal, NSCLC, pancreatic and breast cancer. Daily oral administration of 1, 3, 10, and 30 mg/kg of TAK-733 for 14 days (Days 10 to 23) results in tumor growth delay in the A375 cell-implanted mice (5/group). TAK-733 (35, 70, 100, and 160 mg/kg) also significantly inhibits tumor growth on an intermittent dosing schedule of 3 days per week for 2 weeks (Days 10, 13, 15, 17, 20, and 22). Three partial regressions (PR), a 60% response rate, are observed in mice administered with 30 mg/kg of TAK-733 daily and in mice administered with 160 mg/kg of TAK-733 intermittently. Responses, CR (complete regression) and partial regressions (PR) are also observed in mice administered with 70, 100, and 160 mg/kg of TAK-733 intermittently. The tumor regression rate is more pronounced with the intermittent administration regimen; the greatest reduction in tumor volume is observed at 160 mg/kg (57.29%), versus a maximum reduction of 46.97% at 30 mg/kg once daily. By the last day of administration, tumor growth is significantly (p<0.05 for="" %t/c,="" student's="" t-test)="" inhibited="" in="" mice="" administered="" 3,="" 10,="" and="" 30="" mg/kg="" once="" daily="" or="" 35,="" 70,="" 100,="" and="" 160="" mg/kg="" intermittently="">
- 參考文獻：
1. Dong Q, et al. Discovery of TAK-733, a potent and selective MEK allosteric site inhibitor for the treatment of cancer. Bioorg Med Chem Lett. 2011 Mar 1;21(5):1315-9. 2. Micel LN, et al. Antitumor activity of the MEK inhibitor TAK-733 against melanoma cell lines and patient-derived tumor explants. Mol Cancer Ther. 2015 Feb;14(2):317-25.
- 溶解度： Soluble in DMSO
- 保存條件： -20℃
- 配置溶液濃度參考：
1mg 5mg 10mg 1 mM 1.983 ml 9.916 ml 19.832 ml 5 mM 0.397 ml 1.983 ml 3.966 ml 10 mM 0.198 ml 0.992 ml 1.983 ml 50 mM 0.04 ml 0.198 ml 0.397 ml
- 注意：部分產品我司僅能提供部分信息，我司不保證所提供信息的性，僅供客戶參考交流研究之用。
